Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome.
OBJECTIVE
Patients with a primary neurodegenerative disorder associated with cognitive impairment are at increased risk for epilepsy. The goal of the present study was to characterize seizure type(s), etiological diagnosis of dementia, electroencephalogram (EEG) and imaging findings, and response to antiepileptic drug (AED) therapy in these individuals.


METHODS
A retrospective study was performed identifying patients in the Mayo Alzheimer Disease Patient Registry (ADPR) and Alzheimer Disease Research Center (ADRC) who were classified as having dementia and epilepsy from 1986 to 2006. Multiple clinical parameters were extracted from patient charts and evaluated to characterize the primary neurodegenerative disorder and seizure outcomes.


RESULTS
Sixty-three of the 1738 ADPR and ADRC patients (3.6%) had epilepsy. Twenty-four of the 63 patients were excluded because of insufficient information regarding their epilepsy. The remaining 39 patients were analyzed. Twenty-eight of the 63 patients (72%) experienced complex partial seizures. Head MRI was performed in 35 patients (90%). Fourteen patients (36%) had MRI-identified structural lesions that included remote stroke and prior intracerebral hemorrhage. EEGs were obtained in 29 patients (74%). Fifteen patients (38%) had epileptiform discharges. Overall, it was found that 79% had an excellent response to AED therapy. Approximately one-third of the patients had dose-related side effects from an AED.


CONCLUSIONS
The present study indicated that most individuals with the comorbidity of epilepsy and dementia have complex partial seizures that may be adequately controlled on AED therapy. The long-term effect of seizure activity on the neurodegenerative disorder is unknown.
Rao
Satish C
SC
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Dove
Gerald
G
Cascino
Gregory D
GD
Petersen
Ronald C
RC
D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000150:complications; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D003704:Dementia / Q000150:complications*; D004569:Electroencephalography; D017029:Epilepsy, Complex Partial / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D012640:Seizures / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D000927:Anticonvulsants
Neurochem Res. 2003 Nov;28(11):1649-58
14584819
J Gerontol A Biol Sci Med Sci. 2000 Jul;55(7):M384-92
10898255
Ann Neurol. 1987 Dec;22(6):724-9
3435081
Neurology. 2004 Aug 10;63(3):538-42
15304590
N Engl J Med. 1996 Jan 18;334(3):168-75
8531974
Neuroepidemiology. 2000 Jul-Aug;19(4):194-200
10859498
Neurology. 1986 Sep;36(9):1226-30
3092131
Arch Neurol. 2002 Jul;59(7):1099-106
12117357
Drugs Aging. 2003;20(11):791-803
12964886
N Engl J Med. 2000 Feb 3;342(5):314-9
10660394
Epilepsia. 2004 Jul;45(7):751-6
15230697
Epilepsia. 1993 Nov-Dec;34(6):1007-16
8243349
Prog Neurobiol. 2005 Oct;77(3):166-200
16307840
Epilepsia. 2004;45 Suppl 6:28-34
15315513
Neurology. 1990 Apr;40(4):626-31
2320236
J Geriatr Psychiatry Neurol. 1994 Oct-Dec;7(4):230-3
7826492
Epilepsia. 1998 Oct;39(10):1083-7
9776329
Arch Neurol. 2006 Nov;63(11):1632-8
17101834
Neurology. 2004 Aug 10;63(3):492-7
15304580
Neurology. 1996 Mar;46(3):727-30
8618673
Epilepsia. 2006 May;47(5):867-72
16686651
Epilepsia. 1996 Feb;37(2):141-7
8635424